Abstract | Caspase 8 can initiate apoptosis, but it also has non-apoptotic roles; for example, it is required for embryonic development and immune cell proliferation. Recent work has indicated that the requirement for caspase 8 in development and immune cell proliferation is defined by suppression of receptor-interacting protein kinase 3 (RIPK3), a kinase that triggers an alternative form of cell death called programmed necrosis. Interestingly, these recent findings can be reconciled with earlier work on the non-apoptotic roles of caspase 8. PERSPECTIVES NATURE REVIEWS | MOLECULAR CELL BIOLOGY VOLUME 12 | NOVEMBER 2011 | 757
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. This process, referred to as extrinsic apoptosis, is me diated by a group of receptors of the tumour necrosis factor (TNF) superfamily called the death receptors. These include TNF receptor 1 (TNFR1) and the related receptor CD95 (also known as FAS and APO1) 2 . In addition, death receptor activation can promote cell proliferation and nuclear factor-κB (NF-κB) activation, as discussed below. To trigger apoptosis, death receptors recruit an adaptor protein, FAS-associated death domain (FADD), to their cytoplasmic tails; FADD then recruits caspase 8 proenzymes, which induces their dimerization and thereby activates them
1).
Apoptotic caspase 8 activation is inhibited by another protein, FLICE-like inhibitor y protein long (FLIP L ; referred to here as FLIP). FLIP is homologous to caspase 8 but lacks catalytic residues. FLIP forms a heterodimer with caspase 8 (REF. 3 ), which prevents apoptosis induction
. We discuss the properties of the caspase 8-FLIP heterodimer below.
Apoptotic cell death is a means to delete superfluous or damaged cells; as a consequence, knockout of proteins involved in apoptosis often leads to defects associated with an overabundance of cells [4] [5] [6] [7] [8] . It is therefore surprising that knockout of caspase 8 (REF. 9 ), FADD 10, 11 or FLIP 12 in mice leads to embryonic lethality, first observed around embryonic day 10.5 (E10.5), and failure of yolk sac vascularization and haematopoiesis. This observation led to the hypothesis that these proteins have roles in cellular processes beyond apoptosis. Conditional deletion of FADD 13, 14 or caspase 8 (REF. 15) in lymphoid tissues reinforced this idea: T cells that were deficient for either protein -although resistant to apoptosis induced by CD95 ligation -failed to proliferate upon T cell antigen receptor (TCR) stimulation. The requirement of caspase 8 and FADD for cellular proliferation was extended to B cells stimulated with ligands for Toll-like receptor 3 (TLR3) and TLR4 (REFS 14, 16, 17) . Much effort and many studies have been devoted to explaining these observations, and several non-apoptotic roles have been assigned to caspase 8, FADD and FLIP. All three have been reported to be involved in NF-κB activation [17] [18] [19] [20] , and this requirement was proposed to explain the proliferative defects of caspase 8-deficient T cells and B cells 17, 20 . Caspase 8 has further been implicated in cell motility 21 , metastasis 20 and suppression of inflammation 22, 23 , whereas FADD is reported to be required for normal cell cycle progression [24] [25] [26] . Several years ago, it was observed that in cultured cells in which caspase 8 or FADD are absent or inhibited, TNF treatment causes a non-apoptotic form of cell death that involves cellular swelling and rupture, features commonly associated with necrotic (rather than apoptotic) cell death 27 . Like apoptosis, this alternative form of cell death was found to be 'programmed' , in that it depends on the activation of specific cellular enzymes: receptor-interacting protein kinase 1 (RIPK1) 28 and its downstream partner RIPK3 . These observations led to the idea that the non-apoptotic roles of FADD and caspase 8 might involve the suppression of RIPK3-dependent programmed necrosis. This idea recently received strong genetic support with the finding that concurrent ablation of RIPK1 or RIPK3 rescued the developmental and immune defects associated with FADD 32 or caspase 8 (REFS 33, 34) deficiency. In this Opinion article, we summarize recent work implicating suppression of RIPK signalling as the primary non-apoptotic role of caspase 8. We then revisit and cautiously reinterpret some previously proposed non-apoptotic roles of caspase 8, FADD and FLIP in the context of RIPK signalling.
TNF: complexes and complexities
In considering how caspase 8 might exert its suppression of RIPK signalling, we must first discuss the pleiotropic nature of signalling by the cytokine TNF. It is important to note that there is currently no genetic evidence that the defects observed in caspase 8-or FADD-deficient animals are due to TNF signalling. Nonetheless, TNF signalling is the best-understood framework to study the interconnected pathways of NF-κB activation, apoptosis and programmed necrosis.
The initial events following the ligation of TNFR have been extensively reviewed elsewhere 35, 36 and are summarized in BOX 2. Importantly for the topic at hand, following ligation, TNFR recruits RIPK1 (among other proteins; BOX 2) to form receptor complex I, which activates the NF-κB transcriptional program. FLIP is a transcriptional target of NF-κB, and FLIP upregulation accounts for the non-apoptotic nature of the response to TNF in most cell types if FLIP upregulation is blocked, TNF signalling becomes potently pro-apoptotic 37 . As we discuss below, FLIP is also implicated in the suppression of RIPK3-dependent signalling by caspase 8 and therefore represents a functional link between NF-κB signalling and the prevention of both apoptosis and RIPK3-dependent necrosis (FIG. 2) .
Following complex I formation, RIPK1 translocates to a second complex (complex II) 38 , which is located in the cytosol. This translocation depends on the deubiquitylation of RIPK1 by the deubiquitinase cylindromatosis (CYLD). Complex II was initially described as a site of apoptotic caspase 8 activation 38, 39 . However, when it became clear that RIPK1 also activates RIPK3 to drive programmed necrosis, and that this signalling could be blocked by caspase 8, complex II was re-envisioned as a key site of interaction between the RIPK1-RIPK3 pathway and FADD, caspase 8 and FLIP [29] [30] [31] (FIG. 2) .
Two recent reports present compelling evidence that a RIPK1-containing complex capable of recruiting RIPK3, FADD, caspase 8 and FLIP may form in the cytosol independently of receptor activation 40, 41 in response to multiple cellular signals and stresses
. These studies indicate that this complex represents a signalling 'modul e' that is able to activate either apoptosis (via caspase 8) or programmed necrosis (via RIPK3), and that it can be recruited to multiple signalling platforms, including TNFR or the TLR adaptor TRIF (also known as TICAM1). These findings suggest that the balance between caspase 8, FLIP and RIPK signalling can determine cell fate in response to many different types of cellular signalling and stress, a concept to which we return later.
Caspase 8 blocks RIPK3 signalling Genetic evidence. RIPK3 is highly expressed in adult lymphoid tissue, and the first strong evidence that suppression of programmed necrosis might define the non-apoptotic role of caspase 8 was obtained in T cells. Initial reports showed that caspase 8-deficient T cells failed to accumulate because of prolifer ative defects; however, it was later seen that these cells actually proliferated normally, but did not accumulate owing to increased rates of cell death 42 . Crucially, this cell death was found to be non-apoptotic, and proliferation could be restored in vitro by administration of the RIPK1 inhibitor necrostatin 1 (REF. 42 ).
Subsequent findings showed that concurrent ablation of caspase 8 
CD8
-lymphoid cells 33, 34 . Further work showed that T cell-specific deletion of caspase 8 on a RIPK3-deficient genetic background recapitulates this disorder, indicating that this cell population arises from the T cell lineage 43 . However, the selective events that yield this population remain to be elucidated.
Animals that are deficient for FADD display developmental and immune-cell defects that are similar to those observed in caspase 8 knockouts 11 . Initial work using an inducible Cre recombinase showed that deletion of FADD in the bone marrow leads to a dramatic decrease in haematopoietic precursor cells, as well as to an impaired ability to generate lymphoid and myeloid cells 44 . Subsequent work found that concurrent ablation of RIPK1 prevents the early embryonic lethality observed in FADD-deficient animals 32 . Knockout of RIPK1 alone causes perinatal lethality, and FADD RIPK1 double-knockout animals also die shortly after birth, precluding further analysis of FADD-deficient adults.
FLIP-ing the survival switch
Any discussion of the non-apoptotic role of caspase 8 must address the question of how its proteolytic activity, the activation of which normally leads to apoptotic cell death, can suppress RIPK3 signalling without causin g apoptosis.
Intriguingly, although FLIP inhibits apoptotic activation of caspase 8 by forming heterodimers with the caspase 8 proenzyme
), the resulting caspase 8-FLIP heterodimers possess catalytic activity [45] [46] [47] .
In vitro and structural studies found that caspase 8-FLIP heterodimers form more readily than caspase 8 homodimers because FLIP has greater affinity for the caspase 8 proenzyme than the proenzyme has for itself 45 . This property allows FLIP to activate caspas e 8 even in the absence of the inter domain autocleavage events that are necessary for stabilization and activity of the caspase 8 homodimer 45, 48 . This is important because of the finding that mice expressing only a non-cleavable version of caspase 8
Box 1 | The mechanism of caspase 8 activation
Caspases are present in inactive forms in most cells types. They are synthesized as proenzymes composed of a central large subunit (~20 kDa) and a carboxy-terminal small subunit (~10 kDa). In addition to these domains, the initiator caspases (the enzymes that initiate apoptotic signalling, such as caspases 8, 2 and 9) also possess an amino-terminal prodomain that mediates proteinprotein interactions 76 . Initiator caspase proenzymes (zymogens) remain monomeric until they are recruited to large activation platforms via interactions with their prodomains. These platforms include the death receptor-and receptor-interacting protein kinase 1 (RIPK1)-associated complexes described herein for caspase 8, as well as the cytochrome C-apoptotic proteaseactivatin g factor 1 (APAF1) complex (called the apoptosome) for caspase 9. Once recruited to these platforms, caspase proenzymes are induced to dimerize, and this dimerization leads to enzyme activation 77 (FIG. 1) . In the case of caspase 8, dimerization is followed by interdomain cleavage events, first between the large and small subunits and subsequently between the large subunit and the prodomain. These cleavage events stabilize the caspase 8 homodimer and remove the prodomain, leading to formation of a fully active enzyme composed of two large and two small subunits 78 . Importantly for the current topic, a point mutation that prevents the stabilizing cleavage of caspase 8 between the large and small subunits prevents activation of caspase 8 by prodomain-driven homodimerization 79, 80 . However, this non-cleavable mutant is still able to be activated by heterodimerization with the caspase 8-like protein FLICE-like inhibitory protein long (FLIP L ; referred to here as FLIP) 45, 48, 81 . This caspase 8-FLIP heterodimer is implicated in carrying out the suppression of RIPK3 signalling that defines the non-apoptotic role of caspase 8. However, how this suppression takes place, and how the caspase 8-FLIP complex is prevented from inducing apoptosis, remains unclear. Artificial formation of caspase 8-FLIP heterodimers independently of death receptor ligation using an inducible-dimerization system readily triggers apoptosis 48 , indicating that catalytic differences between the homodimer and heterodimer are not sufficient to explain their distinct functions. It is likely that receptor-mediated signalling exerts additional controls on the caspase 8-FLIP complex, such as restricted localization or rapid degradation, which further limit its cleavage of apoptotic substrates.
display normal development and immune cell activation, but their cells and tissues are resistant to apoptosis 49 . Thus, noncleavable caspase 8 -which can be activated by heterodimerization with FLIP, but not by homodimerization -can carry out the non-apoptotic functions of caspase 8. Reconstitution of caspase 8-deficient mouse embryonic fibroblast (MEF) cells with wildtype or non-cleavable caspase 8 confirmed that non-cleavable caspase 8 is able to suppress RIPK3-dependent necrosis but requires the presence of FLIP to do so 33 (FIG. 2) .
This work indicates that caspase 8 has distinct moieties with different functions: the caspase 8 homodimer causes apoptosis, whereas the catalytically active caspase 8-FLIP heterodimer suppresses RIPK3 signalling and mediates the nonapoptotic role of caspase 8 (REF. 33) (FIG. 2) .
Importantly, when apoptosis is blocked downstream of caspase 8 activation, it was found that FLIP is nonetheless required to prevent RIPK3-dependent necrosis; that is, activation of the caspase 8 homodimer is not sufficient to prevent RIPK3-dependent necrosis 33 . Because FLIP is a transcriptional target of NF-κB, this work identifies FLIP upregulation as a key mechanism by which NF-κB signalling prevents both apoptosis and RIPK3 activation (FIG. 2) . However, the mechanism by which the caspase 8-FLIP complex suppresses RIPK signalling is currently unknown. Both RIPK1 (REF. 50 ) and RIPK3 (REF. 51) have been described as caspase 8 substrates, and a recent study showed that a RIPK1 cleavage-resistant mutant could trigger necrosis even in the presence of caspase 8 activity 52 . Another recent study identified the deubiquitinase CYLD as a key substrate of caspase 8 in the prevention of RIPK-dependent necrosis 53 , although the complex in which the cleavage occurs in vivo remains to be elucidated
.
The above discussion of FLIP signalling has considered only the long isoform of FLIP; however, a short version of FLIP (FLIP S ), which is composed only of the prodomain, also exists 54 . FLIP S can inhibit caspase 8 activation in a dominant-negative fashion by competing for binding to FADD, but it does not possess the ability to activate caspase 8 by heterodimerization. Consistent with the model proposed above, FLIP S is not able to suppress RIPK activation 55 . This distinction is important because many viruses encode anti-apoptotic proteins that are homologous to FLIP S , and programmed necrosis has been implicated in antiviral responses 29, 56 . 
Caspase 8: roles beyond apoptosis
The data outlined above provide strong genetic support for the non-apoptotic functions of caspase 8 and FADD depending on the suppression of the RIPK1-RIPK3 signalling pathway [32] [33] [34] . In light of these findings, it is worthwhile to reconsider some nonapoptotic roles that were previously assigned to caspase 8 and FADD.
Activation of NF-κB signalling. Several reports have sought to explain the defects observed in embryos and immune cells deficien t in caspase 8, FADD or FLIP by implicating these proteins in the induction of NF-κB signalling
. The catalytic activity of caspase 8 was shown to be required for NF-κB activation in antigen-stimulated T cells, and caspase 8 was also found to associate with the CARMA-BCL-10-MALT1 (CARD-containing MAGUK-B cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma translocation 1) complex, which is required for NF-κB activation following antigen receptor ligation in T cells and B cells 57 . Caspase 8 was further shown to interact directly with TNFR-associated factor (TRAF) family members, which promoted translocation of caspase 8 into lipid rafts 58 , and additional work implicated lipid rafts as the site of formation of the caspase 8-FLIP complex and its association with several proteins involved in NF-κB activation 59 . Indeed, FLIP has also been implicated in NF-κB activation, with a number of studies indicating that one or more of the FLIP cleavage fragments generated by association with caspase 8 are involved in NF-κB activation 19, 60 . Some caution must be used in interpreting these studies, as they present work from both mouse and human systems. Unlike mice, humans have the close caspase 8 homologue caspase 10 (REFS 61,62), which displays regulatory and functional properties that are distinct from caspase 8. How the recent discoveries in the mouse system will translate to human models remains an open question.
Nonetheless, the idea that caspase 8 plays a part in NF-κB activation has met with some recent setbacks. The timing and tissues involved in the embryonic lethality of caspase 8-deficient mice are distinct from those observed in NF-κB-related knockout mice, which die at around E13 or E14 owing to liver defects 63, 64 . Furthermore, caspase 8 RIPK3 double-knockout T cells proliferat e normally 33 , without any of the defects observed in T cells lacking NF-κB components 63 , BCL-10, CARMA1 or MALT1 . Indeed, a careful analysis of T cells indicated that caspase 8-deficient cells have normal NF-κB activation, and that the defects associated with caspase 8-deficiency (initial proliferation followed by necrotic death) are distinct from those observed in cells lacking NF-κB signalling (lack of proliferation) 42 . These findings similarly raise questions about the proposed role of caspase 8-cleaved FLIP in NF-κB activation, as caspase 8 deficiency would presumably abolish this protein species. Close analysis of FLIP-deficient T cells 68 and B cells 69 revealed that, although both cell types displayed an increased susceptibility to cell death, NF-κB signalling remained intact.
Beyond T cell activation, both caspase 8 and FADD have also been reported to be required for NF-κB activation and proliferation in B cells, in response to the innate pattern-recognition receptors TLR3 and TLR4 (REFS 17, 70) . In considering the role of FADD and caspase 8 in this context, it is interesting to note that both TLR3 and TLR4 signal through the adaptor protein TRIF. This protein contains a RIP homotypic interaction motif (RHIM) domain and is able to recruit RIPK1 and RIPK3 (REF. 71); it has also been reported to trigger FADD-and caspase 8-dependent apoptosis 72 . A recent report indicated that a RIPK1-containing complex that is capable of triggering both apoptosis and RIPK3-dependent necrosis is recruited to TRIF following TLR3 ligation 40 . This report also showed the presence of FLIP in this
Box 2 | Activation of NF-κB by TNFR
When tumour necrosis factor α (TNFα) binds its trimeric receptor TNF receptor 1 (TNFR1), it induces a conformational change that results in the recruitment of receptor-interacting protein kinase 1 (RIPK1) and TNFR1-associated death domain (TRADD) to the cytoplasmic death domain-containing tail of TNFR1 (REF. 38 ) (see the figure, step 1). These proteins subsequently recruit members of the TNFR-associated factor (TRAF) family, as well as cellular inhibitor of apoptosis 1 (cIAP1; also known as BIRC2) and cIAP2 (also known as BIRC3) 35 . The cIAPs are E3 ubiquitin ligases that catalyse the addition of ubiquitin moieties via non-degradative Lys63 linkages to RIPK1 and TRAF2, as well as to the cIAPs themselves (see the figure, step 2, solid arrows). These modifications in turn allow recruitment of the linear ubiquitin chain assembly complex (LUBAC), which catalyses the addition of linear ubiquitin chains to multiple members of the complex, an event that is believed to stabilize these interactions and allow efficient, sustained signalling 82, 83 (see the figure, step 3). Nuclear factor-κB (NF-κB) essential modulator (NEMO), the core component of the inhibitor of NF-κB (IκB) kinase (IKK) complex, is among the ubiquitylation targets of LUBAC; this modification stably recruits NEMO and the IKK complex. The IKK complex is then phosphorylated and thereby activated by kinases TGFβ-activated kinase 1 (TAK1) and TAK1-binding 2 (TAB2), which associate with ubiquitin linkages attached to RIPK1 (REF. 84 ) (see the figure, step 4, dotted arrows). IKK complex activation leads to the phosphorylation and proteasome-mediated degradation of the inhibitory molecule IκB, which in turn allows activation and nuclear translocation of the NF-κB transcription factor complexes 35 and transcriptional upregulation of NF-κB targets, including FLICE-like inhibitory protein long (FLIP L ; referred to here as FLIP). Following these events, ubiquitin chains are removed from RIPK1 by the deubiquitinase cylindromatosis (CYLD) (see the figure, step 5), which allows RIPK1 to translocate to the cytosol to form a second complex (complex II); this is believed to be the site of functional interaction between RIPK1, RIPK3, FAS-associated death domain (FADD), FLIP and caspase 8 (REFS 29, 39, 55) (FIG. 2) . κ complex and a requirement for this molecule in limiting caspase 8 activation and suppressing RIPK3-dependent necrosis. This study strongly implies that the requirement for FADD, caspase 8 and FLIP in TLR signalling is defined by suppression of RIPK3.
Caspase 8 and inflammation. Several reports have implicated caspase 8 in the suppression of inflammation. It was initially observed that, in mice in which caspase 8 was conditionally deleted in hepatocytes, partial hepatectomy led to a blunted proliferative response followed by chronic inflammation of the liver 73 . Subsequently, it was found that conditional deletion of caspase 8 in basal keratinocytes led to severe and fatal inflammatory skin disease, which could be partially ameliorated by knockout of TNF. Caspase 8-deficient epidermal cells displayed increased inflammatory signalling in response to transfected DNA, which raised the possibility that caspase 8 could suppress an inflammatory pathway downstream of an innate nucleotide sensor 23 . Subsequent work using Sendai virus infection as a model system showed that caspase 8 suppresses activation of the proinflammatory transcription factor interferon regulatory factor 3 (IRF3) through the cytosolic RNA sensor retinoic acid-inducible gene I (RIGI) 22 . Significantly, this suppression was mediated by cleavage of RIPK1, which is recruited to a complex containing RIGI and its adaptor, mitochondrial antiviral signalling protein (MAVS)
Here, again, the phenotype of caspase 8 RIPK3 double-knockout mice must be taken into account. Unlike the skin from mice with the skin-specific knockout of caspase 8, which showed severe epidermal inflammation, the skin from caspase 8 RIPK3 double-knockout animals was entirely normal 33 . This implies that whatever defect provokes inflammation in the absence of caspase 8 is corrected by the removal of RIPK3. Intriguingly, epidermal ablation of NF-κB signalling also causes severe inflammation 74 . FLIP connec ts NF-κB signalling to suppression of the RIPK1-RIPK3 pathway by caspase 8; the possibility therefore emerges that commonalities between epithelial deletion of caspas e 8 and NF-κB signalling could be due to disregulatio n of RIPK1-RIPK3 signalling.
Recent findings from another epithelial model, the gut, also support these ideas 75 . FADD deletion in the gut led to inflammatory bowel disease, an effect that was rescued by concurrent ablation of RIPK3. Importantly, the inflammatory phenotype associated with FADD deletion was also ameliorated by the deletion of TNF or the innate immune adaptor myeloid differentiation primary response 88 (MYD88), or by the elimination of gut microbiota. Similarly to the skin model discussed above, this finding presents how unrestrained RIPK signallin g leads to a multifaceted, self-reinforcing inflammatory response, with TNF signalling and gut barrier breakdown both contributing. NF-κB deletion in this context would be expected to sensitize cells not only to RIPK3-dependent effects but also to apoptosis -an outcome that caspase 8 or FADD deletion obviously prevents. Indeed, it was found that deletion of CYLD -which is required for RIPK activation downstream of TNF -prevented inflammation caused by intestinal deletion of FADD, but not NF-κB signalling 75 . This implies that both apoptosis and RIPK-dependent necrosis contribute to This figure depicts the formation of receptor-interacting protein kinase 3 (RIPK3)-activating complex II, which also contains RIPK1, following tumour necrosis factor receptor 1 (TNFR1) ligation. Recent evidence indicates that a similar complex can be induced by Toll-like receptor 3 (TLR3) or TLR4 ligation or genotoxic stress 40, 41 . TNFR1 ligation initially recruits and ubiquitylates RIPK1 in the receptor-associated complex I
. This triggers nuclear factor-κB (NF-κB) activation and transcriptional upregulation of FLICE-like inhibitory protein long (FLIP L ; referred to here as FLIP)
. RIPK1 is then deubiquitylated and translocates to the cytosol to form the complexes collectively called complex II, some of which are depicted in this figure. In complex II, RIPK1 can recruit FAS-associated death domain (FADD), caspase 8 and/or FLIP in a manner similar to that depicted in FIG. 1 . RIPK1 can also recruit and activate RIPK3 in this complex, a process that is controlled by FADD, caspase 8 and FLIP. a | When both caspase 8 and FLIP are present, these proteins are recruited to the RIPK1-containing complex. The caspase 8-FLIP heterodimer limits RIPK1-RIPK3 signalling but does not trigger apoptosis. The mechanism by which suppression of RIPK1-RIPK3 signalling by the caspase 8-FLIP complex is carried out remains controversial 52, 53 . b | When FLIP levels are low (for example, if NF-κB signalling is prevented), caspase 8 activation is unchecked, leading to apoptosis 40, 41 . FLIP is required not only to limit caspase 8 activation but also for suppression of RIPK signalling 33 , so reduced FLIP levels can also sensitize cells to RIPK3-dependent necrosis if apoptosis is prevented. c | When caspase 8 (or FADD) is absent, apoptotic activation of caspase 8 is prevented but RIPK signalling proceeds unchecked. The result is sensitization to RIPK3-dependent programmed necrosis. CYLD, cylindromatosis; Ub, ubiquitin.
the inflammatory effects of NF-κB deletion. Analysing these effects in a tissue other than the gut, in which any cell death can cause barrier breakdown and thus severe inflammation, will be informative in delineating the relative inflammatory contributions of apoptoti c and necrotic cell death.
Concluding remarks
Recent work provides strong genetic evidence for the idea that suppression of RIPK1-RIPK3 signalling defines the nonapoptotic roles of FADD and caspase 8. Because caspase 8, FADD and FLIP are able to suppress RIPK1-RIPK3-mediated programmed necrosis in cultured cells, it is tempting to conclude that prevention of programmed necrosis defines the nonapoptotic role of these proteins. However, because the pathways of programmed necrosis are so poorly understood, all that can be said definitively is that the death of caspase 8-deficient embryos depends on RIPK3. The cellular processes mediated by RIPK3 in this context, and the signalling events that trigger them, remain unknown. The known roles of RIPK1 and RIPK3 in TNF and innate immune signalling prompted us to reinterpret the proposed non-apoptotic roles for caspase 8, FADD and FLIP in these signalling pathways. However, we have not been exhaustive. FADD has been implicated in cell cycle progression [24] [25] [26] , and caspase 8 has been shown to promote cell motility and affect tumour metastasis 21 . It is possible that these functions are independent of RIPK1-RIPK3 signalling but are simply not required for normal development and survival and therefore do not manifest in double-knockout mice. However, the intriguing possibility exists that these effects of FADD and caspase 8 are due to modulation of unknown effects of RIPK1-RIPK3 signalling. Possible roles for RIPK signalling in these contexts should be re-evaluated and, until the downstream effects of the RIPK pathway are understood, we cannot rule out their involvement.
Box 3 | The role of ubiquitylation
In considering the dynamics of receptor activation, apoptosis and programmed necrosis, it is useful to note the central role of ubiquitylation in these processes. Both degradative and non-degradative ubiquitylation have central roles in the control of nuclear factor-κB (NF-κB) activation, as well as caspase 8 and receptor-interacting protein kinase 1 (RIPK1) signalling 85, 86 . Ubiquitin chains can be linked via several different Lys residues in the ubiquitin monomer, and recent reports show that RIPK1 is targeted by four separate types of ubiquitin linkages during receptor signalling 87 . The deubiquitinase cylindromatosis (CYLD) is required to remove ubiquitin chains from RIPK1, allowing the formation of complex II 39 , and caspase 8 may block programmed necrosis by preventing this process 53 . More-recent reports indicated that degradative ubiquitylation by the ubiquitin ligases cellular inhibitor of apoptosis (cIAP) and X chromosome-linked IAP (XIAP) prevent receptorindependen t formation of a RIPK1-containing complex, termed the ripoptosome, that is capable of triggering caspase 8-mediated apoptosis as well as RIPK3-dependent necrosis 40, 41 . Furthermore, in the context of suppression of RIPK1-mediated inflammation at the retinoic acid-inducible gene I (RIGI) complex by caspase 8, it was reported that Lys63-linked RIPK1 ubiquitylation is required to render RIPK1 susceptible to caspase 8-mediated cleavage, the mechanism by which RIPK1 signalling is reported to be suppressed in this context 22 . Caspase 8 is also modified by non-degradative ubiquitin chains, and intriguingly this modification was reported to allow the activation of non-cleavable caspase 8, a mutant protein that is able to suppress RIPK1 signalling but not to trigger apoptosis 85 . It is therefore possible that dynamic ubiquitylation is at least partially responsible for controlling the activation of caspase 8 by FLICE-like inhibitory protein long (FLIP L ; referred to here as FLIP)
. Degradative ubiquitylation of the caspase 8-FLIP complex has also been reported 41 , and the rapid proteosomal degradation of this complex could explain how it is prevented from triggering apoptosis. The study of the role of these and other post-translational modifications in the dynamics of NF-κB activation, apoptosis and programmed necrosis will be crucial to understanding these interrelated processes.
